State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases & Engineering Research Center of Oral Translational Medicine, Ministry of Education & National Engineering Laboratory for Oral Regenerative Medicine, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China.
Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, No. 14, 3Rd Section of Ren Min Nan Rd., Chengdu, Sichuan 610041, China.
J Mater Chem B. 2022 Apr 20;10(16):3138-3151. doi: 10.1039/d2tb00006g.
3D-printed biphasic calcium phosphate (BCP) scaffolds show great clinical application potential in bone tissue engineering; however, vascularization of the scaffold is a crucial step for bone regeneration and is still difficult to be controlled. To enhance scaffold vascularization, a novel bioactive scaffold loaded with platelet lysate/gelatin methacrylate (PL/GelMA) in a BCP scaffold was proposed for promoting vascularization. The PL/GelMA/BCP scaffold was successfully prepared digital light processing (DLP) printing and filled with PL/GelMA to promote the vascularization effect. evaluation indicated that human umbilical vein endothelial cells (HUVECs) adhered well on the PL/GelMA/BCP scaffold, and cell proliferation was significantly promoted by coculture with the scaffold. Moreover, a variety of growth factors (GFs) in the PL were detected which were slowly released from the scaffold to modulate the cell behaviour and promote the formation of blood vessel-like structures. Co-culturing with the PL/GelMA/BCP scaffold upregulated the expression of angiogenesis-related genes in cells. results showed that a higher capillary formation was also observed in PL/GelMA/BCP scaffolds implanted subcutaneously on the back of the rats. These results indicated that the vascularization ability of BCP was enhanced by filling it with PL/GelMA. The PL/GelMA/BCP scaffold has the potential to promote vascularization in tissue engineering.
3D 打印双相磷酸钙(BCP)支架在骨组织工程中具有巨大的临床应用潜力;然而,支架的血管化是骨再生的关键步骤,仍然难以控制。为了增强支架的血管化,提出了一种新型生物活性支架,在 BCP 支架中加载血小板裂解物/明胶甲基丙烯酰(PL/GelMA),以促进血管化。PL/GelMA/BCP 支架通过数字光处理(DLP)打印成功制备,并填充 PL/GelMA 以促进血管化效果。评估表明,人脐静脉内皮细胞(HUVEC)在 PL/GelMA/BCP 支架上黏附良好,与支架共培养可显著促进细胞增殖。此外,PL 中的多种生长因子(GFs)被检测到,并从支架中缓慢释放,以调节细胞行为并促进血管样结构的形成。与 PL/GelMA/BCP 支架共培养可上调细胞中血管生成相关基因的表达。结果表明,在大鼠背部皮下植入 PL/GelMA/BCP 支架也观察到更高的毛细血管形成。这些结果表明,填充 PL/GelMA 可增强 BCP 的血管化能力。PL/GelMA/BCP 支架具有促进组织工程中血管化的潜力。